Genovis AB (publ.) (STO:GENO)
Sweden · Delayed Price · Currency is SEK 19.30
-0.62 (-3.11%)
Sep 22, 2026, 5:29 PM CET
Genovis AB (publ.) Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 135.61 | 128.95 | 130.36 | 158.23 | 102.39 | 93.02 |
Other Revenue | 0.28 | 0.28 | 0.25 | 0.84 | 1.18 | 0.66 |
| 135.89 | 129.23 | 130.61 | 159.07 | 103.56 | 93.68 | |
Revenue Growth | 11.16% | -1.06% | -17.89% | 53.60% | 10.55% | 53.49% |
Cost of Revenue | 15.44 | 13.8 | 16.1 | 15.16 | 15.02 | 11.73 |
Gross Profit | 120.45 | 115.43 | 114.51 | 143.91 | 88.54 | 81.95 |
Selling, General & Admin | 82.09 | 76.09 | 75.69 | 79.35 | 68.19 | 52.85 |
Other Operating Expenses | -1.51 | -0.75 | -1.08 | -0.04 | -0.1 | 0.15 |
Operating Expenses | 95.51 | 87.61 | 85.06 | 89.03 | 74.72 | 58.77 |
Operating Income | 24.93 | 27.82 | 29.45 | 54.88 | 13.82 | 23.18 |
Interest Expense | -4.06 | -3.77 | -3.96 | -2.26 | -0.34 | - |
Interest & Investment Income | 2.76 | 2.76 | 4.46 | 2.89 | 0.06 | 0.06 |
Earnings From Equity Investments | 6.29 | 6.54 | 0.1 | - | - | - |
Currency Exchange Gain (Loss) | -0.02 | -5.15 | 1.36 | -0.65 | 3.33 | 1.37 |
EBT Excluding Unusual Items | 29.91 | 28.19 | 31.4 | 54.85 | 16.87 | 24.6 |
Merger & Restructuring Charges | -4.78 | -1.29 | - | - | - | - |
Gain (Loss) on Sale of Assets | -0.1 | -0.1 | 14.93 | - | - | - |
Other Unusual Items | - | - | - | - | -8.87 | - |
Pretax Income | 25.03 | 26.81 | 46.33 | 54.85 | 8 | 24.6 |
Income Tax Expense | 4.53 | 3.31 | 13.41 | -6.65 | -3.2 | -0.17 |
Net Income | 20.5 | 23.5 | 32.92 | 61.5 | 11.19 | 24.78 |
Net Income to Common | 20.5 | 23.5 | 32.92 | 61.5 | 11.19 | 24.78 |
Net Income Growth | -23.97% | -28.61% | -46.48% | 449.55% | -54.83% | 284.39% |
Shares Outstanding (Basic) | 66 | 66 | 65 | 65 | 65 | 65 |
Shares Outstanding (Diluted) | 66 | 66 | 65 | 65 | 65 | 65 |
Shares Change | 1.12% | 0.48% | - | - | - | 0.58% |
EPS (Basic) | 0.31 | 0.36 | 0.50 | 0.94 | 0.17 | 0.38 |
EPS (Diluted) | 0.31 | 0.36 | 0.50 | 0.94 | 0.17 | 0.38 |
EPS Growth | -24.81% | -28.95% | -46.48% | 449.55% | -54.83% | 282.19% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 47.95 | 30.44 | 36.03 | 57.31 | -3.86 | 44.15 |
Free Cash Flow Per Share | 0.72 | 0.46 | 0.55 | 0.88 | -0.06 | 0.67 |
Gross Margin | 88.63% | 89.32% | 87.67% | 90.47% | 85.50% | 87.48% |
Operating Margin | 18.35% | 21.53% | 22.55% | 34.50% | 13.35% | 24.74% |
Profit Margin | 15.08% | 18.18% | 25.20% | 38.66% | 10.81% | 26.45% |
Free Cash Flow Margin | 35.28% | 23.55% | 27.58% | 36.03% | -3.73% | 47.13% |
EBITDA | 32.93 | 33.16 | 33.42 | 58.41 | 16.63 | 24.94 |
EBITDA Margin | 24.23% | 25.66% | 25.59% | 36.72% | 16.06% | 26.62% |
D&A For EBITDA | 8 | 5.34 | 3.97 | 3.53 | 2.81 | 1.76 |
EBIT | 24.93 | 27.82 | 29.45 | 54.88 | 13.82 | 23.18 |
EBIT Margin | 18.35% | 21.53% | 22.55% | 34.50% | 13.35% | 24.74% |
Effective Tax Rate | 18.11% | 12.35% | 28.95% | - | - | - |
Revenue as Reported | 144.86 | 132.83 | 150.93 | 164.95 | 110.13 | 96.25 |